AbCellera Biologics Inc vs DENTSPLY SIRONA Inc — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | XRAY | |
|---|---|---|
Market Cap | $2.99B | $2.31B |
Sector | Health | Health |
52-Week High | $9.76 | $14.68 |
52-Week Low | $2.78 | $9.64 |
Enterprise Value | $2.58B | $4.39B |
Dividend Yield | — | 5.04% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →